Other
HCC
0
Pipeline Programs↗
6
Active Trials↗
1
Companies Involved↗
HCC is an early-stage landscape with 0 programs across 1 company. The most active players are Bayer.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
16
clinical trials
Unknown status6 · 38%
Recruiting6 · 38%
Terminated2 · 13%
Withdrawn1 · 6%
Completed1 · 6%
Clinical Trials
Trial Activity
16 trials
Checkpoint Inhibitor Combinations Therapy as First Line for HCC Via IT
Recruiting·SSecond Affiliated Hospital of Guangzhou Medical University·Phase 2·NCT06482801·90 enrolled
IIT2025-03-YANG-LIFT-HCC
Recruiting·—·Phase 2·NCT07489976·41 enrolled
Comparing SonoVue With Sonazoid Using CEUS-LIRADS in HCC
Unknown status·SSecond Affiliated Hospital, School of Medicine, Zhejiang University·Phase 3·NCT04006275·100 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)